TY  - GEN
AU  - Kao,Jia-Horng
AU  - Lee,Youn-Jae
AU  - Heo,Jeong
AU  - Ahn,Sang-Hoon
AU  - Lim,Young-Suk
AU  - Peng,Cheng-Yuan
AU  - Chang,Ting-Tsung
AU  - Torbeyns,Anne
AU  - Hughes,Eric
AU  - Bhore,Rafia
AU  - Noviello,Stephanie
TI  - All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
SN  - 1478-3231
PY  - 2017///1024
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Alanine Transaminase
KW  - blood
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Asian People
KW  - Carbamates
KW  - Double-Blind Method
KW  - Drug Resistance, Viral
KW  - genetics
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Imidazoles
KW  - International Cooperation
KW  - Isoquinolines
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Pyrrolidines
KW  - RNA, Viral
KW  - Sulfonamides
KW  - Sustained Virologic Response
KW  - Valine
KW  - analogs & derivatives
KW  - Viral Load
KW  - Viral Nonstructural Proteins
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1111/liv.13128
ER  -